Samantha Garbers, PhD works with a diverse range of clinical- and community-based stakeholders to develop, adapt, implement, and evaluate innovative interventions to improve public health for diverse populations including sexual and gender minority youth and adults, adolescent males and women seeking reproductive health care, Latinx and Black communities, and individuals with limited health literacy. Using her training as an epidemiologist, Dr. Garbers works with stakeholders to integrate rigorous methods for process and outcome evaluation into interventions, with a focus on reproductive health. She is currently Co-Principal Investigator of an NIMHD-funded study to develop and test an intervention integrating mind-body integrative health approaches with sleep hygiene to improve sleep among teens served in school-based health centers in NYC. She recently served as Lead Evaluator for a federally-funded randomized controlled trial of a motivational interviewing intervention for teen pre
2021-02-18 13:00:00
Innovations in strengthening health systems preparedness to address violence against women: learnings from providing accessible, quality, and gender-responsive services LSHTM Gender Violence & Health Theme: Health systems and service response to violence
Despite increasing recognition of violence against women (VAW) as a public health problem, health systems have been slow to track, anticipate, respond and prevent such violence. However, since the launch of the World Health Organization (WHO) clinical and policy guidelines for responding to VAW, several countries have implemented or used their principles in low resource settings, adapting them to their health systems and political contexts. This webinar presents findings, challenges and lessons learned from these efforts.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES .
Daxor CorporationFebruary 5, 2021 GMT
NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from the Center for Advancing Point of Care Technologies (CAPCaT), a program run by the Massachusetts Medical Device Development Center (M2D2) funded by the National Heart, Lung, and Blood Institute and the National Center for Complementary and Integrative Health, both part of the National Institutes of Health (NIH), to develop a smart, point-of-care heart failure diagnostic for quantification of intravascular fluid overload to enable precision diuretic dosing.
World first study on mixing covid vaccines begins in Liverpool
The study will also examine the effects of time intervals between first and second doses
Covid-19 vaccinations sign
Three times a day plus breaking news for the biggest stories - sign up for the Liverpool Echo newsletterInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
After analyzing the genomes of more than one-quarter of a million military veterans, a team of scientists, led by researchers at University of California San Diego, Veterans Affairs San Diego Healthcare System (VASDHS), Yale University and West Haven VA, have identified 18 specific, fixed positions on chromosomes (known as loci) that appear associated with post-traumatic stress disorder (PTSD).